Samarium-153-EDTMP Biodistribution and Dosimetry Estimation

Fifty-two patients were treated with single doses of 153Sm-EDTMP in a Phase I escalating dose protocol for palliation of bone pain from metastatic prostate carcinoma. Samarium-153 (T1/2 46.3 hr), maximum beta-particle energies 810 keV (20%), 710 keV (30%), 640 keV (50%), gamma photon 103 keV (28%),...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of nuclear medicine (1978) 1993-07, Vol.34 (7), p.1031
Hauptverfasser:	Eary, Janet F, Collins, Carolyn, Stabin, Michael, Vernon, Cheryl, Petersdorf, Steve, Baker, Melissa, Hartnett, Shelley, Ferency, Sandra, Addison, Stanley J, Appelbaum, Frederick, Gordon, Edwin E
Format:	Artikel
Sprache:	eng
Schlagworte:	Bone Neoplasms - diagnostic imaging Bone Neoplasms - radiotherapy Bone Neoplasms - secondary Chelating Agents - therapeutic use Humans Male Organometallic Compounds - therapeutic use Organophosphorus Compounds - therapeutic use Palliative Care Prostatic Neoplasms - pathology Radioisotopes - therapeutic use Radionuclide Imaging Radiotherapy Dosage Samarium - therapeutic use Technetium Tc 99m Medronate Tissue Distribution
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!